| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Caldwell J, Sever PS |
The biochemical pharmacology of abused drugs 1. Amphetamines, cocaine,... |
Clin.Pharmacol.Ther. |
1974 |
| Smith JM, Misiak H |
Critical Flicker Frequency (CFF) and Psychotropic Drugs in Normal Huma... |
Psychopharmacology |
1976 |
| Renfroe CL, Messinger TA |
Street drug analysis: an eleven year perspective on illicit drug alter... |
Semin Adolesc Med |
1985 |
| Climko RP, Roehrich H, Sw... |
Ecstacy: a review of MDMA and MDA |
Int J Psychiatry Med |
1986 |
| Seiden LS, Kleven MS |
Methamphetamine and related drugs: toxicity and resulting behavioral c... |
NIDA Res Monogr |
1989 |
| Gibb JW, Johnson M, Hanso... |
Neurochemical basis of neurotoxicity |
Neurotoxicology |
1990 |
| Gibb JW, Johnson M, Stone... |
MDMA: historical perspectives |
Ann N Y Acad Sci |
1990 |
| Kosten TR |
Neurobiology of abused drugs. Opioids and stimulants |
J Nerv Ment Dis |
1990 |
| McKenna DJ, Peroutka SJ |
Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine ... |
J Neurochem |
1990 |
| Chiang CN, Hawks RL |
Research Findings on Smoking of Abused Substances |
NIDA Research Monogr... |
1990 |
| Rattray M |
Ecstasy: towards an understanding of the biochemical basis of the acti... |
Essays Biochem |
1991 |
| Kaskey GB |
Possible interaction between an MAOI and 'ecstasy' |
Am J Psychiatry |
1992 |
| Green AR, Cross AJ, Goodw... |
Review of the pharmacology and clinical pharmacology of 3,4-methylened... |
Psychopharmacology (... |
1995 |
| Demirkiran M, Jankovic J,... |
Ecstasy intoxication: an overlap between serotonin syndrome and neurol... |
Clin Neuropharmacol |
1996 |
| Dar KJ, McBrien ME |
MDMA induced hyperthermia: report of a fatality and review of current ... |
Intensive Care Med |
1996 |
| White SR, Obradovic T, Im... |
The effects of methylenedioxymethamphetamine (MDMA, 'Ecstasy') on mono... |
Prog Neurobiol |
1996 |
| Seiden LS, Sabol KE |
Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possi... |
NIDA Res Monogr |
1996 |
| Ropero-Miller JD, Goldber... |
Recreational drugs. Current trends in the 90s |
Clin Lab Med |
1998 |
| Sprague JE, Everman SL, N... |
An integrated hypothesis for the serotonergic axonal loss induced by 3... |
Neurotoxicology |
1998 |
| Moeller MR, Steinmeyer S,... |
Determination of drugs of abuse in blood |
J Chromatogr B Biome... |
1998 |
| Rochester JA, Kirchner JT |
Ecstasy (3,4-methylenedioxymethamphetamine): history, neurochemistry, ... |
J Am Board Fam Pract |
1999 |
| Kintz P, Samyn N |
Determination of 'Ecstasy' components in alternative biological specim... |
J Chromatogr B Biome... |
1999 |
| Parrott AC, Sisk E, Turne... |
Psychobiological problems in heavy `ecstasy' (MDMA) polydrug users |
Drug Alcohol Depend |
2000 |
| Morgan MJ |
Ecstasy (MDMA): a review of its possible persistent psychological effe... |
Psychopharmacology (... |
2000 |
| Weir E |
Raves: a review of the culture, the drugs and the prevention of harm |
Canadian Medical Ass... |
2000 |
| Maurer HH, Bickeboeller-F... |
Toxicokinetics and analytical toxicology of amphetamine-derived design... |
Toxicol Lett |
2000 |
| Ricaurte GA, Yuan J, McCa... |
(+/-)3,4-Methylenedioxymethamphetamine (`Ecstasy')-Induced Serotonin N... |
Neuropsychobiology |
2000 |
| Mieczkowski T, Newel R |
Statistical examination of hair color as a potential biasing factor in... |
Forensic Sci Int |
2000 |
| Anderson C |
Water intake probed in death |
Boulder Daily Camera |
2001 |
| Baggott M, Jerome L, Stua... |
3,4-Methylenedioxymethamphetamine (MDMA): A Review of the English-Lang... |
MAPS.org |
2001 |
| Bankson MB, Cunningham KA |
3,4-Methylenedioxymethamphetamine (MDMA) as a Unique Model of Serotoni... |
Journal of Pharmacol... |
2001 |
| Parrott AC |
Human psychopharmacology of ecstasy; A review of 15 years of empirical... |
Hum Psychopharm Clin... |
2001 |
| Reneman L, Booij J, Majo... |
Investigating the potential neurotoxicity of Ecstasy (MDMA): an imagin... |
Hum Psychopharmacol ... |
2001 |
| Soar K, Turner JJD, Parr... |
Psychiatric disorders in Ecstasy (MDMA) users: a literature review foc... |
Hum Psychopharmacol ... |
2001 |
| Logan BK, Couper FJ |
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairme... |
J Forensic Sci |
2001 |
| Vollenweider FX |
Brain mechanisms of hallucinogens and entactogens |
Dialogues Clin Neuro... |
2001 |
| Kish SJ |
How strong is the evidence that brain serotonin neurons are damaged in... |
Pharmacol Biochem Be... |
2002 |
| Kraemer T, Maurer HH |
Toxicokinetics of amphetamines: metabolism and toxicokinetic data of d... |
Ther Drug Monit |
2002 |
| Moeller MR, Kraemer T |
Drugs of abuse monitoring in blood for control of driving under the in... |
Ther Drug Monit |
2002 |
| Rothman R, Baumann M |
Therapeutic and adverse actions of serotonin transporter substrates |
Pharmacol Ther |
2002 |
| Freese T, Miotto K, Rebac... |
The effects and consequences of selected club drugs |
J Subst Abuse Treat |
2002 |
| Montoya AG, Sorrentino R,... |
Long-Term Neuropsychiatric Consequences of 'Ecstasy' (MDMA): A Review |
Harv Rev Psychiatry |
2002 |
| Romanelli F, Smith KM, Po... |
Use of club drugs by HIV-seropositive and HIV-seronegative gay and bis... |
Top HIV Med |
2003 |
| Lyles J, Cadet JL |
Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular ... |
Brain Res Brain Res ... |
2003 |
| Cole JC, Sumnall HR |
The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamp... |
Neurosci Biobehav Re... |
2003 |
| Cole JC, Sumnall HR |
Altered states: The clinical effects of Ecstasy |
Pharmacology and The... |
2003 |
| Halpern JH |
Hallucinogens: an update |
Curr Psychiatry Rep |
2003 |
| Colado MI, O'Shea E, Gree... |
Acute and long-term effects of MDMA on cerebral dopamine biochemistry ... |
Psychopharmacology (... |
2004 |
| Parrott AC |
Is ecstasy MDMA? A review of the proportion of ecstasy tablets contain... |
Psychopharmacology (... |
2004 |
| de la Torre R, Farre M, M... |
Response to Sprague and Nichols: Contribution of metabolic activation ... |
Trends in Pharmacolo... |
2005 |
| Staack RF, Maurer HH |
Metabolism of designer drugs of abuse |
Curr Drug Metab |
2005 |
| Britt GC, McCance-Katz EF |
A brief overview of the clinical pharmacology of 'club drugs' |
Subst Use Misuse |
2005 |
| Allott K, Redman J |
Are there sex differences associated with the effects of ecstasy/3,4-m... |
Neurosci Biobehav Re... |
2007 |
| Rogers G, Elston J, Garsi... |
The harmful health effects of recreational ecstasy: a systematic revie... |
Health Technol Asses... |
2009 |
| Nutt DJ |
Equasy-- an overlooked addiction with implications for the current deb... |
J Psychopharmacol |
2009 |
| Tupper KW |
Entheogenic healing: The spiritual effects and therapeutic potential o... |
Book: The Healing Po... |
2009 |
| Mendelson JE, Tolliver BK... |
Capsaicin, an active ingredient in pepper sprays, increases the lethal... |
Forensic Toxicol |
2010 |
| Rodgers J, Buchanan T, He... |
'Ecstasy use, by itself, does not result in residual neurotoxicity'- a... |
Addiction |
2011 |
| Parrott AC |
Residual neurocognitive features of ecstasy use: a re-interpretation o... |
Addiction |
2011 |
| Halpern JH, Sherwood AR, ... |
Reply to Parrott (2011), Fisk et al (2011) and Rodgers et al (2011) |
Addiction |
2011 |
| Hart CL, Marvin CB, Silve... |
Is Cognitive Functioning Impaired in Methamphetamine Users? A Critical... |
Neuropsychopharmacol... |
2011 |
| Gatch MB, Gonzalez Maeso ... |
The HIV antiretroviral drug efavirenz has LSD-like properties |
Neuropsychopharmacol... |
2013 |
| Dybdal-Hargreaves NF, Hol... |
Mephedrone: Public health risk, mechanisms of action, and behavioral e... |
Eur J Pharmacol |
2013 |
| Szabo A |
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Op... |
Front Immunol |
2015 |
| Papaseit E, Pérez-Mañá C,... |
Human Pharmacology of Mephedrone in Comparison to MDMA |
Neuropsychopharmacol... |
2016 |
| Karila L, Lafaye G, Scoca... |
MDPV and α-PVP use in humans: The twisted sisters |
Neuropharmacology |
2017 |
| Passie T |
The early use of MDMA ('Ecstasy') in psychotherapy (1977-1985) |
Drug Science, Policy... |
2018 |
